Ignite Creation Date:
2024-05-06 @ 8:04 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06247722
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2024-01-22
Brief Title:
Real World Use of Tocilizumab Biosimilar studY
Sponsor:
Fresenius Kabi SwissBioSim GmbH
Organization:
Fresenius Kabi SwissBioSim GmbH
Organization Data
Organization:
Fresenius Kabi SwissBioSim GmbH
Class:
INDUSTRY
Study ID:
TOCI-001-CNI
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fresenius Kabi SwissBioSim GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None